|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/69 | |
| A61P 35/00 | |||
| A61K 38/00 | |||
| C12Q 1/68 |
| (11) | Patento numeris | 2776043 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12847968.0 |
| Europos patento paraiškos padavimo data | 2012-11-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-09-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-02-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/064496 |
| Data | 2012-11-09 |
| (87) | Numeris | WO 2013/071142 |
| Data | 2013-05-16 |
| (30) | Numeris | Data | Šalis |
| 201161558474 P | 2011-11-11 | US | |
| 201261721818 P | 2012-11-02 | US |
| (72) |
BERGER, Allison, US
CHATTOPADHYAY, Nibedita, US
KOENIG, Erik, M., US
|
| (73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
| (54) | BIOMARKERS OF RESPONSE TO PROTEASOME INHIBITORS |
| BIOMARKERS OF RESPONSE TO PROTEASOME INHIBITORS |